<DOC>
	<DOC>NCT02932969</DOC>
	<brief_summary>The purpose of this Phase 1 study is to evaluate the safety, tolerability, PK, and pharmacodynamics (PD) of BMS-986231 in healthy Japanese and Non-Asian participants. There is no formal hypothesis to be statistically tested.</brief_summary>
	<brief_title>Study With Healthy Japanese and Non-Asian Participants With BMS-986231</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Ancestry First generation Japanese NonAsian with grandparents and parents of nonAsian descent Body weight greater than or equal to 45kg and less than or equal to 110kg Women of childbearing potential have specific birthcontrol methods Males sexually active with women of childbearing potential have specific birthcontrol methods History of chronic illness Chronic headaches Recurrent dizziness Personal or family history of heart disease Personal history of bleeding diathesis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>